6505--Neuraceq - Radiopharmaceuticals
ID: 36C24124Q0723Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF241-NETWORK CONTRACT OFFICE 01 (36C241)TOGUS, ME, 04330, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b65a91ec7ab44128b8f4d500e4524f82/view
Timeline
    Description

    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking a sole source procurement for Neuraceq - Radiopharmaceuticals. Neuraceq is a radioactive diagnostic agent used for Positron Emission Tomography (PET) imaging of the brain. It is used to estimate -amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline. The procurement involves the preparation and delivery of F-18 Florbetaben (NeuraCeq) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. The deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ.

    Point(s) of Contact
    Jerry ChoinskiContracting Specialist
    (203) 932-5711
    jerry.choinski@va.gov
    Files
    Title
    Posted
    36C24124Q0723.docx
    Lifecycle
    Title
    Type
    6505--Neuraceq - Radiopharmaceuticals
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--Pylarify 2026 (VA-26-00025867) RFI
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide F18 PSMA Pylarify, a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer, to the Baltimore VA Medical Center. The procurement aims to identify contractors capable of manufacturing, preparing, and transporting this specialized radiopharmaceutical in compliance with stringent regulatory standards, including USNRC, DOT, and FDA guidelines. Pylarify is critical for diagnosing prostate cancer by identifying PSMA-positive lesions, thus playing a vital role in patient care. Interested parties must submit their responses, including company information and qualifications, by December 17, 2025, at 10:00 AM EST, to Contract Specialist Michael Jones at michael.jones16@va.gov.
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--Notice of Intent to Award a Sole Source Procurement - Xofigo Radium-223 dichloride
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to Cardinal Health for the procurement of 660 units of XOFIGO® (Radium-223 dichloride). This procurement is based on a letter from Bayer Healthcare, which designates Cardinal Health as the sole distributor of XOFIGO® in the United States, highlighting the critical nature of this pharmaceutical in treating specific medical conditions. Interested parties may submit capability statements or proposals within seven days of the notice's publication, with the deadline set for December 19, 2025; otherwise, the contract will be awarded to Cardinal Health without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    Y90 SIR Spheres
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Y-90 SIR Spheres microspheres for use in Selective Internal Radiation Therapy (SIRT) at the North Texas Medical Center in Dallas, Texas. This contract involves the purchase of five unit doses of Sie-Spheres Y90 resin microspheres, estimated at $17,750 per dose, to ensure the availability of this critical treatment for patients with liver tumors. The unique characteristics of these microspheres, provided solely by Sirtex Medical, are essential for delivering targeted radiation therapy, as they are designed to lodge in tumor arterioles while minimizing exposure to healthy tissue. Interested parties can contact Contract Specialist Robert Clark at robert.clark15@va.gov or by phone at 512-228-1088 for further details regarding this procurement, which is justified under FAR 13.106-1 and is expected to exceed the micro-purchase threshold but remain under the simplified acquisition threshold of $250,000.
    6515-- CT MOTION INJECTOR | 678-26-1-071-0007
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking bids for a firm-fixed-price contract (36C26226Q0194) to procure two GE Healthcare CT Motion Pedestal Injectors or equivalent. The injectors must meet specific requirements, including 24-hour multiple pump use, mobility, data import/export capabilities, and various monitoring features, which are essential for enhancing medical imaging procedures. Interested vendors should submit their quotes by December 15, 2025, at 4:00 PM PST, and direct any questions to Contract Specialist Debby Abraham via email by December 12, 2025, at 4:00 PM PST. The acquisition is unrestricted, with a NAICS code of 339112 and a size standard of 1000 employees.
    6515--NEW <$25K | NuTrace R+ Scanner a 2D DataMatrix
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential suppliers for the NuTrace R+ Two Dimensional (2D) Surgiscan for the VA Reno Health Care System. The objective is to gather market research on vendors capable of providing this medical equipment, which is crucial for the Sterile Processing Services (SPS) at the facility. This procurement effort is part of the VA's strategy to assess industry capabilities and support acquisition planning, with a firm-fixed-price contract anticipated for a performance period of 120 days following the award. Interested vendors must submit their expressions of interest, along with relevant business information, to Contract Specialist Haunani Freeman at darralynn.freeman@va.gov by 5:00 PM Hawaii Standard Time on January 29, 2025.
    H358--Notice of Intent to Sole Source: Radiation Safety Officer 3 Months
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, Veterans Health Administration (VHA), is seeking to issue a Sole Source Award for Radiation Safety Officer (RSO) services to Krueger Gilbert Physics for a three-month period at the VA Medical Center located in Washington, DC. This procurement is necessary to ensure the continuity of radiation safety services while a long-term contract is pending due to recent changes in agency requirements and an extended approval process. The unique challenges of hiring qualified RSOs in the Washington D.C. Metro Area, including high demand and stringent regulatory compliance, underscore the importance of this interim solution. Interested parties may submit capability statements to Contract Specialist Charles Willis at charles.willis@va.gov by 1 PM Eastern Time on December 19, 2025, for potential future opportunities.
    Radiopharmaceutical Laboratory Services (RLS) MAMC
    Dept Of Defense
    The Department of Defense, specifically the Madigan Army Medical Center, is conducting market research to identify qualified vendors capable of providing comprehensive Radiopharmaceutical Laboratory Services (RLS). The procurement aims to ensure that vendors can meet stringent requirements, including compliance with FDA standards, The Joint Commission accreditation, and the ability to deliver a range of specified radiopharmaceuticals on a 24/7 basis, including urgent requests. These services are critical for supporting medical operations that rely on radiopharmaceuticals for diagnostics and treatment. Interested parties must submit their capability statements to Cindy Means and Scott Barr by December 19, 2025, at 4:00 PM Pacific Time, detailing their qualifications and ability to meet the outlined requirements.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    Sources Sought - GE Venue Go R4
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contract Office 17, is seeking responses for a Sources Sought Notice regarding the acquisition of a Venue Go R4 Focus Package and associated probes for the Amarillo VA Medical Center's CathLab. This procurement aims to enhance the capabilities of physicians in detecting arterial blockages through the provision of a Venue Ultrasound Unit, which will include all necessary system components for echocardiographs and interventional studies, adhering to relevant guidelines during installation. Interested parties must submit their responses by December 16, 2025, at 10:00 AM CT, including essential business information and an authorization letter from GE Precision Healthcare Ultrasound Systems, with inquiries directed to Rafael Rodriguez at Rafael.Rodriguez2@va.gov or (254) 560-0262.